Proliferative dysfunction in chronically activated T lymphocytes from chagasic patients (70.1)
| dc.contributor.author | Nicolás A. Giraldo | |
| dc.contributor.author | Natalia I. Bolaños | |
| dc.contributor.author | Adriana Cuéllar | |
| dc.contributor.author | Nubia Roa | |
| dc.contributor.author | Zulma M. Cucunubá | |
| dc.contributor.author | Víctor Manuel Velasco | |
| dc.contributor.author | Fernando Rosas | |
| dc.contributor.author | Concepción J. Puerta | |
| dc.contributor.author | John Mario González | |
| dc.coverage.spatial | Bolivia | |
| dc.date.accessioned | 2026-03-22T16:56:15Z | |
| dc.date.available | 2026-03-22T16:56:15Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | Abstract Background: Trypanosoma cruzi persistence has been associated with cardiac and gastrointestinal tissue damage in nearly 30% of the infected individuals; however, the pathogenic mechanisms are yet unknown. This study’s goal was to compare the activation status and proliferative capacity of T lymphocytes among chronic chagasic patients and uninfected controls. Methodology: Twenty-seven chronic chagasic patients, 20 healthy individuals and 28 non-chagasic cardiomyopathy donors were analyzed. Peripheral blood cells were stained with CD3, CD4, CD8, CD28, HLA-DR and CD38. PBMCs were labeled with CFSE and co-cultivated with PHA or T. cruzi lysate; at the fifth day post-stimulation cells were stained for CD3, CD4 and CD8. Results: Chagasic patients displayed higher frequencies of CD4+ (P=0.0001) and CD8+ (P=0.0002) T cells co-expressing HLA-DR and CD38 in comparison with healthy and non-chagasic cardiomyopathy donors. Also, the former group exhibited lower percentages of CD8+/CD28+ T lymphocytes (P=0.0005). After 5 days of stimulation, the proliferation index was lower in both CD4+ (P=0.01) and CD8+ (P=0.04) PHA-stimulated T cells from chagasic donors when compared with both control groups. Conclusions: Despite their increased activation status, the T lymphocytes from chagasic donors displayed reduced proliferative capacity after mitogenic stimulation, corroborating a dysfunctional cellular immune response in the chronic stages of the disease. | |
| dc.identifier.doi | 10.4049/jimmunol.188.supp.70.1 | |
| dc.identifier.uri | https://doi.org/10.4049/jimmunol.188.supp.70.1 | |
| dc.identifier.uri | https://andeanlibrary.org/handle/123456789/61198 | |
| dc.language.iso | en | |
| dc.publisher | American Association of Immunologists | |
| dc.relation.ispartof | The Journal of Immunology | |
| dc.source | Universidad de Los Andes | |
| dc.subject | CD38 | |
| dc.subject | CD28 | |
| dc.subject | CD8 | |
| dc.subject | Chagas disease | |
| dc.subject | CD3 | |
| dc.subject | Immunology | |
| dc.subject | Immune system | |
| dc.subject | Peripheral blood mononuclear cell | |
| dc.subject | Cardiomyopathy | |
| dc.subject | Stimulation | |
| dc.title | Proliferative dysfunction in chronically activated T lymphocytes from chagasic patients (70.1) | |
| dc.type | article |